Advanced SearchSearch Tips
Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 48, Issue 12,  2015, pp.702-707
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2015.48.12.158
 Title & Authors
Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress
Kim, Pyung-Hwan; Na, Sang-Su; Lee, Bomnaerin; Kim, Joo-Hyun; Cho, Je-Yoel;
  PDF(new window)
To overcome the disadvantages of stem cell-based cell therapy like low cell survival at the disease site, we used stanniocalcin 2 (STC2), a family of secreted glycoprotein hormones that function to inhibit apoptosis and oxidative damage and to induce proliferation. STC2 gene was transfected into two kinds of stem cells to prolong cell survival and protect the cells from the damage by oxidative stress. The stem cells expressing STC2 exhibited increased cell viability and improved cell survival as well as elevated expression of the pluripotency and self-renewal markers (Oct4 and Nanog) under sub-lethal oxidative conditions. Up-regulation of CDK2 and CDK4 and down-regulation of cell cycle inhibitors p16 and p21 were observed after the delivery of STC2. Furthermore, STC2 transduction activated pAKT and pERK 1/2 signal pathways. Taken together, the STC2 can be used to enhance cell survival and maintain long-term stemness in therapeutic use of stem cells.
Mesenchymal stem cells;Oxidative stress;Stanniocalcin-2;Stem cell-based therapy;
 Cited by
STC2 as a novel mediator for Mus81-dependent proliferation and survival in hepatocellular carcinoma, Cancer Letters, 2017, 388, 177  crossref(new windwow)
Mimeault M, Hauke R and Batra SK (2007) Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 82, 252-264 crossref(new window)

Estrada JC, Torres Y, Benguria A et al (2013) Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy. Cell Death Dis 4, e691 crossref(new window)

Sart S, Ma T and Li Y (2014) Preconditioning stem cells for in vivo delivery. Biores Open Access 3, 137-149 crossref(new window)

Salem HK and Thiemermann C (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28, 585-596

Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN and Papamichail M (2006) Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24, 462-471 crossref(new window)

Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A and Nikbin B (2006) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7, 14 crossref(new window)

Bahmani B, Roudkenar MH, Halabian R, Jahanian-Najafabadi A, Amiri F and Jalili MA (2014) Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress. Cell Stress Chaperones 19, 685-693 crossref(new window)

Sakata H, Niizuma K, Wakai T, Narasimhan P, Maier CM and Chan PH (2012) Neural stem cells genetically modified to overexpress cu/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. Stroke 43, 2423-2429 crossref(new window)

Yeung BH, Law AY and Wong CK (2012) Evolution and roles of stanniocalcin. Mol Cell Endocrinol 349, 272-280 crossref(new window)

Wagner GF and Dimattia GE (2006) The stanniocalcin family of proteins. J Exp Zool A Comp Exp Biol 305, 769-780 crossref(new window)

Chang AC, Jellinek DA and Reddel RR (2003) Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10, 359-373 crossref(new window)

Tamura S, Oshima T, Yoshihara K et al (2011) Clinical significance of STC1 gene expression in patients with colorectal cancer. Anticancer Res 31, 325-329

Fujiwara Y, Sugita Y, Nakamori S et al (2000) Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers. Int J Oncol 16, 799-804

Kim SJ, Ko JH, Yun JH et al (2013) Stanniocalcin-1 protects retinal ganglion cells by inhibiting apoptosis and oxidative damage. PLoS One 8, e63749 crossref(new window)

Wu LM, Hui L, Guo R et al (2014) Stanniocalcin-1 protects bovine intestinal epithelial cells from oxidative stress-induced damage. J Vet Sci 15, 475-483 crossref(new window)

Wu S, Yoshiko Y and De Luca F (2006) Stanniocalcin 1 acts as a paracrine regulator of growth plate chondrogenesis. J Biol Chem 281, 5120-5127 crossref(new window)

Westberg JA, Serlachius M, Lankila P, Penkowa M, Hidalgo J and Andersson LC (2007) Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke 38, 1025-1030 crossref(new window)

Levy O, Zhao W, Mortensen LJ et al (2013) mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation. Blood 122, e23-32 crossref(new window)

Baghbaderani BA, Mukhida K, Hong M, Mendez I and Behie LA (2011) A review of bioreactor protocols for human neural precursor cell expansion in preparation for clinical trials. Curr Stem Cell Res Ther 6, 229-254 crossref(new window)

Wang K, Zhang T, Dong Q, Nice EC, Huang C and Wei Y (2013) Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis 4, e537 crossref(new window)

Das B, Bayat-Mokhtari R, Tsui M et al (2012) HIF-2alpha suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells. Stem Cells 30, 1685-1695 crossref(new window)

Liu TC, Ismail S, Brennan O, Hastings C and Duffy GP (2013) Encapsulation of cardiac stem cells in superoxide dismutase-loaded alginate prevents doxorubicin-mediated toxicity. J Tissue Eng Regen Med 7, 302-311 crossref(new window)

Zhong J, Chan A, Morad L, Kornblum HI, Fan G and Carmichael ST (2010) Hydrogel matrix to support stem cell survival after brain transplantation in stroke. Neurorehabil Neural Repair 24, 636-644 crossref(new window)

Kim PH, Yim HG, Choi YJ et al (2014) Injectable multifunctional microgel encapsulating outgrowth endothelial cells and growth factors for enhanced neovascularization. J Control Release 187, 1-13 crossref(new window)

Okabe H, Satoh S, Kato T et al (2001) Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61, 2129-2137

Bouras T, Southey MC, Chang AC et al (2002) Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62, 1289-1295

Wang H, Wu K, Sun Y et al (2012) STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro. BMB Rep 45, 629-634 crossref(new window)

de Almeida PE, Ransohoff JD, Nahid A and Wu JC (2013) Immunogenicity of pluripotent stem cells and their derivatives. Circ Res 112, 549-561 crossref(new window)

Le Blanc K (2006) Mesenchymal stromal cells: Tissue repair and immune modulation. Cytotherapy 8, 559-561 crossref(new window)

Hsiao ST, Dilley RJ, Dusting GJ and Lim SY (2014) Ischemic preconditioning for cell-based therapy and tissue engineering. Pharmacol Ther 142, 141-153 crossref(new window)

Satyanarayana A and Kaldis P (2009) Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 28, 2925-2939 crossref(new window)

Hydbring P and Larsson LG (2010) Cdk2: a key regulator of the senescence control function of Myc. Aging (Albany NY) 2, 244-250 crossref(new window)

Gogolin S, Ehemann V, Becker G et al (2013) CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage. Cell Cycle 12, 1091-1104 crossref(new window)

Romanov VS, Pospelov VA and Pospelova TV (2012) Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry (Mosc) 77, 575-584

Sheppard KE and McArthur GA (2013) The cell-cycle regulator CDK4: an emerging therapeutic target in melanoma. Clin Cancer Res 19, 5320-5328 crossref(new window)

Tsai CC, Su PF, Huang YF, Yew TL and Hung SC (2012) Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol Cell 47, 169-182 crossref(new window)

Baer PC, Griesche N, Luttmann W, Schubert R, Luttmann A and Geiger H (2010) Human adipose-derived mesenchymal stem cells in vitro: evaluation of an optimal expansion medium preserving stemness. Cytotherapy 12, 96-106 crossref(new window)

Go MJ, Takenaka C and Ohgushi H (2008) Forced expression of Sox2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp Cell Res 314, 1147-1154 crossref(new window)